|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Revenue | ||
| Cost of revenue | ||
| Gross profit | ||
| Operating expenses | ||
| Research and development | ||
| Sales and marketing | ||
| General and administrative | ||
| Total operating expenses | ||
| Operating income (loss) | ||
| Interest income | ||
| Income (loss) before income taxes | ||
| Income tax (benefit) provision | ||
| Net income (loss) | ||
| Net income (loss) per share attributable to common stockholders: | ||
| Basic (in dollars per share) | ||
| Diluted (in dollars per share) | ||
| Weighted-average shares used in calculating net income (loss) per share attributable to common stockholders: | ||
| Basic (in shares) | ||
| Diluted (in shares) | ||
| Other comprehensive income | ||
| Unrealized gain on marketable securities, net of taxes | ||
| Total other comprehensive income (loss) | ||
| Total comprehensive income (loss) |
Loading...
